 Connection
Gina Kruse to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Gina Kruse has written about Uterine Cervical Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.949 |
|
|
|
-
Kruse GR, Lykken JM, Kim EJ, Haas JS, Higashi RT, Atlas SJ, McCarthy AM, Tiro JA, Silver MI, Skinner CS, Kamineni A. Provider beliefs in effectiveness and recommendations for primary HPV testing in 3 health-care systems. JNCI Cancer Spectr. 2023 01 03; 7(1).
Score: 0.598
-
Higashi RT, Quirk L, Kruse G, Chen PM, Dang TH, Haas JS, Atlas SJ, Feldman S, Kobrin SC, Lee SC, Santini N, Tiro JA. Process Mapping to Compare and Improve Management of Abnormal Cervical Cancer Screening Results in Two US Healthcare Systems within the PROSPR Consortium. Cancer Epidemiol Biomarkers Prev. 2025 Nov 03; 34(11):1989-1999.
Score: 0.182
-
Sheridan L, Pocobelli G, Anderson M, Li CI, Kruse GR, Tiro JA, Kamineni A. Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019. Cancer Causes Control. 2025 Mar; 36(3):275-284.
Score: 0.170
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|